Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 29 of 35

COMPLETED Phase 2

Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)

NCT00896181

COMPLETED Phase 2

TRIAD - Treatment of Insomnia and Depression

NCT00767624

COMPLETED Early Phase 1

Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee

NCT00800098

COMPLETED NA

Effect of Fish Oil on Plasma Triglycerides in Adults

NCT00804427

COMPLETED NA

Computer-Based Physical Activity Advice for Ethnic Minority Aging Adults

NCT01144767

COMPLETED Phase 1

Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision

NCT00812890

COMPLETED Phase 1

Building Better Caregivers Online: An Online Workshop for Caregivers of Those With Traumatic Brain Injury, Post Traumatic Stress Disorder, or Alzheimer's or Other Dementia

NCT00799786

COMPLETED Phase 2

NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients

NCT00809094

COMPLETED Phase 3

Early Childhood Prevention of Childhood Overweight

NCT00896545

COMPLETED Phase 1

A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

NCT00442611

TERMINATED Phase 4

Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

NCT03020472

COMPLETED

In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.

NCT00788255

COMPLETED Phase 3

Internet Chronic Disease Self-Management Program for Australia

NCT00787956

COMPLETED NA

Stress Reduction During In Vitro Fertilization

NCT00788502

COMPLETED Phase 3

Doctors and Web-based Self-management Support Pilot Study

NCT01220310

TERMINATED

Immunobiology of Cancer

NCT00767533

COMPLETED

Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

NCT00801762

COMPLETED

Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia

NCT01364272

COMPLETED NA

Effect of IV Lidocaine Infusions on Pain

NCT00725504

COMPLETED NA

Teaching Math Skills to Individuals With Fragile X Syndrome

NCT01204151

COMPLETED NA

Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery

NCT00804609

TERMINATED Phase 2

Insulin Resistance in Pulmonary Arterial Hypertension

NCT00825266

TERMINATED Phase 3

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia

NCT01364259

COMPLETED

Prevention of Childhood Obesity

NCT00788203

COMPLETED

Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.

NCT00767832

COMPLETED Phase 4

Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II

NCT00186043

TERMINATED

Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

NCT01137162

TERMINATED

Permission to Collect Blood Over Time for Research

NCT00767234

COMPLETED Phase 4

Topical Antibiotics and Intravitreous Injections

NCT00410891

TERMINATED

Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

NCT01135355

COMPLETED Phase 3

PMP-300E (Smart Watch): Portable Monitoring Device Study

NCT01364740

COMPLETED NA

A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).

NCT00725361

COMPLETED

Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)

NCT01349946

COMPLETED NA

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

NCT01314963

COMPLETED Phase 2

An Open-Label Study of N-Acetyl Cysteine in Children With Autism

NCT00676195

COMPLETED

Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)

NCT00786227

COMPLETED

Epidemiology of H. Pylori Transmission

NCT02740140

COMPLETED

Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age

NCT00238576

COMPLETED NA

Effect of Ondansetron for Withdrawal Symptoms

NCT00695864

COMPLETED Phase 2

Vivamos Activos Fair Oaks Program for Weight Loss in Low Income Latinos

NCT01242683

COMPLETED Phase 3

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

NCT01108016

COMPLETED Phase 1

Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia

NCT00683956

COMPLETED Phase 2

Development of Vitamin D as a Therapy for Breast Cancer - Phase 2

NCT00656019

COMPLETED

Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma

NCT00715819

COMPLETED

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

NCT01144793

COMPLETED Early Phase 1

Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure

NCT00657280

COMPLETED

Marital Functioning Among Combat Veterans

NCT01031654

COMPLETED NA

Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal

NCT00661674

TERMINATED

Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI

NCT00695968

COMPLETED NA

Feasibility Study of a Novel Device for Chronic Wounds

NCT00660049

← Previous Page 29 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.